Anebulo Pharmaceuticals, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| English Aron R. | — | Purchase | 10,101,010 | $0.99 | $10,000,000 | 15,467,300 | Dec 23, 2024 |
| 22NW, LP | — | Gift | 300,000 | — | — | 5,366,290 | Dec 18, 2023 |
| English Aron R. | — | Award / Grant | 1,703,577 | $2.81 | $4,787,051 | 5,066,290 | Sep 28, 2022 |
| 22NW Fund, LP | — | Purchase | 400 | $6.59 | $2,636 | 3,362,713 | Dec 17, 2021 |
| 22NW Fund, LP | — | Purchase | 412 | $5.90 | $2,431 | 3,362,313 | Dec 14, 2021 |
| 22NW Fund, LP | — | Purchase | 4,500 | $5.93 | $26,685 | 3,361,901 | Dec 3, 2021 |
| 22NW Fund, LP | — | Purchase | 13,836 | $5.30 | $73,331 | 3,357,401 | Dec 2, 2021 |
| 22NW Fund, LP | — | Award / Grant | 714,250 | $7.00 | $4,999,750 | 3,343,565 | May 6, 2021 |
| 22NW, LP | — | Award / Grant | 714,286 | $7.00 | $5,000,002 | 3,343,601 | May 6, 2021 |